NCT03296046已完成不适用
Epidemiologic Study of Persistent Polyclonal B-cell Lymphocytosis (PPBL) - Observatory 1990-2012
Central Hospital, Nancy, France2 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2012年11月13日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 100
- 试验地点
- 2
- 主要终点
- Relevant medical history
研究概览
简要总结
The main purpose of this study is the description of all French cases of PPBL and the establishment of minimal criteria for the pathology diagnosis and its follow-up.
The secondary objective is the immunologic and genetic characterization of lymphoid cells causing the disease.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Cross Sectional
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •PPBL diagnosis established during a previous medical visit
排除标准
- 未提供
结局指标
主要结局
Relevant medical history
时间窗: Baseline
Administration of first-line treatment or not
时间窗: Baseline
Complete blood count
时间窗: Baseline
次要结局
- Lymphocyte phenotype(Baseline)
研究者
研究点 (2)
Loading locations...
相似试验
招募中
不适用
MPS (RaDiCo Cohort) (RaDiCo-MPS)Mucopolysaccharidosis IMucopolysaccharidosis IIMucopolysaccharidosis IIIMucopolysaccharidosis IVMucopolysaccharidosis VIMucopolysaccharidosis VIIMucopolysaccharidosis IXMultiple Sulfatase Deficiency DiseaseNCT06036693Institut National de la Santé Et de la Recherche Médicale, France1,000
已完成
不适用
French National Registry of Children Born Small for Gestational Age Treated With SomatropinGrowth DisorderSmall for Gestational AgeNCT01578135Novo Nordisk A/S291
尚未招募
不适用
Familial B-cell Lymphoproliferative DisordersLymphoproliferative DisordersPremalignantMonoclonal B-Cell LymphocytosisChronic Lymphocytic LeukemiaNCT05718986University of Haifa1,000
进行中（未招募）
不适用
National Clinical-biological Prospective Cohort of Incident Cases of Aggressive Fibromatosis (ALTITUDES)Aggressive FibromatosisNCT02867033Centre Oscar Lambret628
招募中
不适用
Management and Clinical Outcomes of Patients With Severe Mitral Valve Disease Not Suitable for SurgeryMitral Valve DiseaseNCT02925819French Cardiology Society500